Interaction Between the Vaginal and Seminal Microbiome in Patients With an Altered Vaginal Microbiome Pattern Resistant to Treatment
NCT ID: NCT04641390
Last Updated: 2021-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2021-02-01
2022-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective of the project is to identify the interaction of the vaginal and seminal microbiome patterns in couples in which the vaginal pattern is altered and is persistent to drug treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microbiome Influence on Seminal Quality
NCT04784260
Study of Sperm Molecular Factors Implicated in Male Fertility
NCT00481403
Study of the ZyMōt Sperm Selection Method and Its Effect on Embryo Ploidy.
NCT06384794
The Association of Gut Microbiota and Spermatogenic Dysfunction
NCT05628987
Effect of Antioxidant Probiotic Administration on Seminal Quality and Reproductive Outcomes.
NCT04585984
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Casos
altered vaginal microbiome resistant to drug treatment
Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome resistant to drug treatment
The analysis of the seminal microbiome will be carried out by massive genetic sequencing
Controles
Altered vaginal microbiome not resistant to drug treatment
Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome not resistant to drug treatment
The analysis of the seminal microbiome will be carried out by massive genetic sequencing
semen donors
The semen donors included in the present work will be men between 18 and 35 years old who are included in the donation program of Instituto Bernabeu after having passed a series of physical, psychological, analytical, genetic and serological evaluations and are considered suitable for donation as established by Royal Decree-Law 9/2014. Likewise, donors are subjected to a series of seminal quality evaluations and seminal freeze-thaw tests in order to guarantee their fertile potential. In this way, the donors who are part of the Instituto Bernabeu donation program also comply with current legal regulations with a strict evaluation to be considered the gold standard of potentially fertile semen. In addition, it will be necessary for them to provide a signed informed consent accepting their participation in the study.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome resistant to drug treatment
The analysis of the seminal microbiome will be carried out by massive genetic sequencing
Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome not resistant to drug treatment
The analysis of the seminal microbiome will be carried out by massive genetic sequencing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males will be between 18 and 50 years old
* Signed informed consent accepting their participation in the study.
* Male donors will be between 18 and 35 years old
Exclusion Criteria
* Men who are under treatment with antibiotics
* Men who have an active sexually transmitted disease
* Men who have a chronic prostatitis or a urinary infection (such as epididymitis or orchitis).
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Bernabeu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Belen Lledo
Laboratory service manager
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Miguel Hernández
Sant Joan d'Alacant, Alicante, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
InstitutoBernabeu2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.